Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: a prospective study in 110 patients - Colao,A.; Di Sarno,A.; Landi,M.L. (J Clin Endocrinol Metab, 2000)